Clinical Trials Update: Sep. 26, 2003

Asthma (Pediatric) Epilepsy Binge Eating Disorder

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Asthma (Pediatric)

A research study of an investigational medication for asthma. Volunteers ages 2-8 with mild persistent asthma or a history of at least 3 or more episodes of wheezing in the previous year that lasted more than one day and affected sleep may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat442.html.

-----

Epilepsy

A study to evaluate the safety and effectiveness of a marketed anti-seizure drug in women with catamenial epilepsy. Female volunteers ages 18-40 who have catamenial epilepsy and are currently on at least one, but no more than two anti-seizure drugs, may be eligible. Research site located in Saint Paul, Minnesota.

More Information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

-----

Binge Eating Disorder

A study to examine whether the medication sertraline (Zoloft) is effective in the treatment of binge eating disorder (BED) among overweight children and adolescents. Overweight volunteers 8-18 who have a clinical diagnosis of binge eating disorder for at least 6 months prior to study entry may be eligible. Research site located in New York, New York.

More Information

Please see http://www.centerwatch.com/patient/studies/cat616.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com